{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:05:30Z","timestamp":1790417130418,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,12,6]],"date-time":"2012-12-06T00:00:00Z","timestamp":1354752000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1038\/npp.2012.255","type":"journal-article","created":{"date-parts":[[2013,1,9]],"date-time":"2013-01-09T08:34:26Z","timestamp":1357720466000},"page":"938-949","source":"Crossref","is-referenced-by-count":238,"title":["Microglia, Amyloid, and Glucose Metabolism in Parkinson\u2019s Disease with and without Dementia"],"prefix":"10.1038","volume":"38","author":[{"given":"Paul","family":"Edison","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imtiaz","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Hinz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Gelosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ray Chaudhuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuzana","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico E","family":"Turkheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,12,6]]},"reference":[{"key":"BFnpp2012255_CR1","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.neuroimage.2007.02.017","volume":"36","author":"AN Anderson","year":"2007","unstructured":"Anderson AN, Pavese N, Edison P, Tai YF, Hammers A, Gerhard A et al (2007). A systematic comparison of kinetic modelling methods generating parametric maps for [(11)C]-(R)-PK11195. Neuroimage 36: 28\u201337.","journal-title":"Neuroimage"},{"key":"BFnpp2012255_CR2","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F et al (2000). The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123 Pt 11 2321\u20132337.","journal-title":"Brain"},{"key":"BFnpp2012255_CR3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1002\/mds.1212","volume":"16","author":"G Berding","year":"2001","unstructured":"Berding G, Odin P, Brooks DJ, Nikkhah G, Matthies C, Peschel T et al (2001). Resting regional cerebral glucose metabolism in advanced Parkinson\u2019s disease studied in the off and on conditions with [(18)F]FDG-PET. Mov Disord 16: 1014\u20131022.","journal-title":"Mov Disord"},{"key":"BFnpp2012255_CR4","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00429-010-0246-0","volume":"214","author":"P Borghammer","year":"2010","unstructured":"Borghammer P, Chakravarty M, Jonsdottir KY, Sato N, Matsuda H, Ito K et al (2010). Cortical hypometabolism and hypoperfusion in Parkinson\u2019s disease is extensive: probably even at early disease stages. Brain Struct Funct 214: 303\u2013317.","journal-title":"Brain Struct Funct"},{"key":"BFnpp2012255_CR5","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1016\/j.neuroimage.2009.05.040","volume":"47","author":"P Borghammer","year":"2009","unstructured":"Borghammer P, Cumming P, Aanerud J, Forster S, Gjedde A (2009). Subcortical elevation of metabolism in Parkinson\u2019s disease--a critical reappraisal in the context of global mean normalization. Neuroimage 47: 1514\u20131521.","journal-title":"Neuroimage"},{"key":"BFnpp2012255_CR6","first-page":"1614","volume":"38","author":"G Brix","year":"1997","unstructured":"Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H et al (1997). Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38: 1614\u20131623.","journal-title":"J Nucl Med"},{"key":"BFnpp2012255_CR7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1177\/089198878800100106","volume":"1","author":"JL Cummings","year":"1988","unstructured":"Cummings JL (1988). Intellectual impairment in Parkinson\u2019s disease: clinical, pathologic, and biochemical correlates. J Geriatr Psychiatry Neurol 1: 24\u201336.","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"BFnpp2012255_CR8","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/jcbfm.1993.5","volume":"13","author":"VJ Cunningham","year":"1993","unstructured":"Cunningham VJ, Jones T (1993). Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 13: 15\u201323.","journal-title":"J Cereb Blood Flow Metab"},{"key":"BFnpp2012255_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0197-4580(94)90028-0","volume":"15","author":"JL Eberling","year":"1994","unstructured":"Eberling JL, Richardson BC, Reed BR, Wolfe N, Jagust WJ (1994). Cortical glucose metabolism in Parkinson\u2019s disease without dementia. Neurobiol Aging 15: 329\u2013335.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2012255_CR10","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1016\/j.nbd.2008.08.001","volume":"32","author":"P Edison","year":"2008","unstructured":"Edison P, Archer HA, Gerhard A, Hinz R, Pavese N, Turkheimer FE et al (2008a). Microglia, amyloid, and cognition in Alzheimer\u2019s disease: An [11C](R)PK11195-PET and [11C]PIB-PET study. Neurobiol Dis 32: 412\u2013419.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2012255_CR11","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF et al (2007). Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology 68: 501\u2013508.","journal-title":"Neurology"},{"key":"BFnpp2012255_CR12","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N et al (2008b). Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79: 1331\u20131338.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"BFnpp2012255_CR13","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R, Burn DJ, Duyckaerts C, Mizuno Y et al (2007). Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22: 1689\u20131707.","journal-title":"Mov Disord"},{"key":"BFnpp2012255_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1179\/174313208X300396","volume":"30","author":"T Feng","year":"2008","unstructured":"Feng T, Wang Y, Ouyang Q, Duan Z, Li W, Lu L et al (2008). Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson\u2019s disease. Neurol Res 30: 377\u2013382.","journal-title":"Neurol Res"},{"key":"BFnpp2012255_CR15","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.nbd.2005.08.002","volume":"21","author":"A Gerhard","year":"2006","unstructured":"Gerhard A, Pavese N, Hotton G, Turkheimer F, Es M, Hammers A et al (2006). In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson\u2019s disease. Neurobiol Dis 21: 404\u2013412.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2012255_CR16","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1212\/01.wnl.0000326146.60732.d6","volume":"71","author":"SN Gomperts","year":"2008","unstructured":"Gomperts SN, Rentz DM, Moran E, Becker JA, Locascio JJ, Klunk WE et al (2008). Imaging amyloid deposition in Lewy body diseases. Neurology 71: 903\u2013910.","journal-title":"Neurology"},{"key":"BFnpp2012255_CR17","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1002\/hbm.10123","volume":"19","author":"A Hammers","year":"2003","unstructured":"Hammers A, Allom R, Koepp MJ, Free SL, Myers R, Lemieux L et al (2003). Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe. Hum Brain Mapp 19: 224\u2013247.","journal-title":"Hum Brain Mapp"},{"key":"BFnpp2012255_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1749-6632.2003.tb07478.x","volume":"991","author":"EC Hirsch","year":"2003","unstructured":"Hirsch EC, Breidert T, Rousselet E, Hunot S, Hartmann A, Michel PP (2003). The role of glial reaction and inflammation in Parkinson\u2019s disease. Ann NY Acad Sci 991: 214\u2013228.","journal-title":"Ann NY Acad Sci"},{"key":"BFnpp2012255_CR19","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/mds.22444","volume":"24","author":"Y Hosokai","year":"2009","unstructured":"Hosokai Y, Nishio Y, Hirayama K, Takeda A, Ishioka T, Sawada Y et al (2009). Distinct patterns of regional cerebral glucose metabolism in Parkinson\u2019s disease with and without mild cognitive impairment. Mov Disord 24: 854\u2013862.","journal-title":"Mov Disord"},{"key":"BFnpp2012255_CR20","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/brain\/123.2.340","volume":"123","author":"MT Hu","year":"2000","unstructured":"Hu MT, Taylor-Robinson SD, Chaudhuri KR, Bell JD, Labbe C, Cunningham VJ et al (2000). Cortical dysfunction in non-demented Parkinson\u2019s disease patients: a combined (31)P-MRS and (18)FDG-PET study. Brain 123 Pt 2 340\u2013352.","journal-title":"Brain"},{"key":"BFnpp2012255_CR21","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1212\/WNL.54.8.1596","volume":"54","author":"TA Hughes","year":"2000","unstructured":"Hughes TA, Ross HF, Musa S, Bhattacherjee S, Nathan RN, Mindham RH et al (2000). A 10-year study of the incidence of and factors predicting dementia in Parkinson\u2019s disease. Neurology 54: 1596\u20131602.","journal-title":"Neurology"},{"issue":"1","key":"BFnpp2012255_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.parkreldis.2012.07.002","volume":"19","author":"S. Iannaccone","year":"2013","unstructured":"Iannaccone S, Cerami C, Alessio M, Garibotto V, Panzacchi A, Olivieri S et al (2012). In vivo microglia activation in very early dementia with Lewy bodies, comparison with Parkinson\u2019s disease. Parkinsonism Relat Disord (in press) doi:10.1016\/j.parkreldis.2012.07.002.","journal-title":"Parkinsonism & Related Disorders"},{"key":"BFnpp2012255_CR23","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1007\/s00401-006-0088-2","volume":"112","author":"KA Jellinger","year":"2006","unstructured":"Jellinger KA, Attems J (2006). Does striatal pathology distinguish Parkinson disease with dementia and dementia with Lewy bodies? Acta Neuropathol 112: 253\u2013260.","journal-title":"Acta Neuropathol"},{"key":"BFnpp2012255_CR24","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1212\/WNL.0b013e3181d55f61","volume":"74","author":"JC Klein","year":"2010","unstructured":"Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S et al (2010). Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74: 885\u2013892.","journal-title":"Neurology"},{"issue":"Suppl 1","key":"BFnpp2012255_CR25","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/j.neurobiolaging.2011.09.006","volume":"32","author":"WE Klunk","year":"2011","unstructured":"Klunk WE (2011). Amyloid imaging as a biomarker for cerebral beta-amyloidosis and risk prediction for Alzheimer dementia. Neurobiol Aging 32 (Suppl 1): S20\u2013S36.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2012255_CR26","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1523\/JNEUROSCI.23-06-02086.2003","volume":"23","author":"WE Klunk","year":"2003","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Shao L et al (2003). The binding of 2-(4\u2032-methylaminophenyl)benzothiazole to postmortem brain homogenates is dominated by the amyloid component. J Neurosci 23: 2086\u20132092.","journal-title":"J Neurosci"},{"issue":"Suppl 13","key":"BFnpp2012255_CR27","first-page":"S69","volume":"21","author":"T-W Liang","year":"2006","unstructured":"Liang T-W, Noorigian JV, Duda. JE (2006). Does striatal pathology distinguish PDD from DLB? Mov Disord 21 (Suppl 13): S69.","journal-title":"Mov Disord"},{"key":"BFnpp2012255_CR28","first-page":"1959","volume":"46","author":"BJ Lopresti","year":"2005","unstructured":"Lopresti BJ, Klunk WE, Mathis CA, Hoge JA, Ziolko SK, Lu X et al (2005). Simplified Quantification of Pittsburgh Compound B Amyloid Imaging PET Studies: a comparative analysis. J Nucl Med 46: 1959\u20131972.","journal-title":"J Nucl Med"},{"key":"BFnpp2012255_CR29","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.nbd.2008.12.008","volume":"34","author":"W Maetzler","year":"2009","unstructured":"Maetzler W, Liepelt I, Reimold M, Reischl G, Solbach C, Becker C et al (2009). Cortical PIB binding in Lewy body disease is associated with Alzheimer-like characteristics. Neurobiol Dis 34: 107\u2013112.","journal-title":"Neurobiol Dis"},{"key":"BFnpp2012255_CR30","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","volume":"39","author":"W Maetzler","year":"2008","unstructured":"Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K et al (2008). [11C]PIB binding in Parkinson\u2019s disease dementia. Neuroimage 39: 1027\u20131033.","journal-title":"Neuroimage"},{"key":"BFnpp2012255_CR31","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1196\/annals.1332.007","volume":"1035","author":"PL McGeer","year":"2004","unstructured":"McGeer PL, McGeer EG (2004). Inflammation and the degenerative diseases of aging. Ann N Y Acad Sci 1035: 104\u2013116.","journal-title":"Ann N Y Acad Sci"},{"key":"BFnpp2012255_CR32","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/ana.10728","volume":"54","author":"PL McGeer","year":"2003","unstructured":"McGeer PL, Schwab C, Parent A, Doudet D (2003). Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration. Ann Neurol 54: 599\u2013604.","journal-title":"Ann Neurol"},{"key":"BFnpp2012255_CR33","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/nrneurol.2009.217","volume":"6","author":"A Nordberg","year":"2010","unstructured":"Nordberg A, Rinne JO, Kadir A, Langstrom B (2010). The use of PET in Alzheimer disease. Nat Rev Neurol 6: 78\u201387.","journal-title":"Nat Rev Neurol"},{"key":"BFnpp2012255_CR34","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1001\/archneur.1992.00530360060019","volume":"49","author":"RF Peppard","year":"1992","unstructured":"Peppard RF, Martin WR, Carr GD, Grochowski E, Schulzer M, Guttman M et al (1992). Cerebral glucose metabolism in Parkinson\u2019s disease with and without dementia. Arch Neurol 49: 1262\u20131268.","journal-title":"Arch Neurol"},{"key":"BFnpp2012255_CR35","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/jnr.490270417","volume":"27","author":"RF Peppard","year":"1990","unstructured":"Peppard RF, Martin WR, Clark CM, Carr GD, McGeer PL, Calne DB (1990). Cortical glucose metabolism in Parkinson\u2019s and Alzheimer\u2019s disease. J Neurosci Res 27: 561\u2013568.","journal-title":"J Neurosci Res"},{"key":"BFnpp2012255_CR36","doi-asserted-by":"publisher","first-page":"2837","DOI":"10.1093\/brain\/awm238","volume":"130","author":"KE Pike","year":"2007","unstructured":"Pike KE, Savage G, Villemagne VL, Ng S, Moss SA, Maruff P et al (2007). {Beta}-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer\u2019s disease. Brain 130 Pt 11 2837\u20132844.","journal-title":"Brain"},{"key":"BFnpp2012255_CR37","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G et al (2010). Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31: 1275\u20131283.","journal-title":"Neurobiol Aging"},{"key":"BFnpp2012255_CR38","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1007\/BF03164661","volume":"6","author":"M Sasaki","year":"1992","unstructured":"Sasaki M, Ichiya Y, Hosokawa S, Otsuka M, Kuwabara Y, Fukumura T et al (1992). Regional cerebral glucose metabolism in patients with Parkinson\u2019s disease with or without dementia. Ann Nucl Med 6: 241\u2013246.","journal-title":"Ann Nucl Med"},{"key":"BFnpp2012255_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/0969-8051(94)90022-1","volume":"21","author":"F Shah","year":"1994","unstructured":"Shah F, Hume SP, Pike VW, Ashworth S, McDermott J (1994). Synthesis of the enantiomers of [N-methyl-11C]PK 11195 and comparison of their behaviours as radioligands for PK binding sites in rats. Nucl Med Biol 21: 573\u2013581.","journal-title":"Nucl Med Biol"},{"key":"BFnpp2012255_CR40","doi-asserted-by":"publisher","first-page":"2601","DOI":"10.1088\/0031-9155\/45\/9\/313","volume":"45","author":"TJ Spinks","year":"2000","unstructured":"Spinks TJ, Jones T, Bloomfield PM, Bailey DL, Miller M, Hogg D et al (2000). Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol 45: 2601\u20132618.","journal-title":"Phys Med Biol"},{"key":"BFnpp2012255_CR41","first-page":"158","volume":"48","author":"FE Turkheimer","year":"2007","unstructured":"Turkheimer FE, Edison P, Pavese N, Roncaroli F, Anderson AN, Hammers A et al (2007). Reference and target region modeling of [11C]-(R)-PK11195 brain studies. J Nucl Med 48: 158\u2013167.","journal-title":"J Nucl Med"},{"key":"BFnpp2012255_CR42","first-page":"797","volume":"38","author":"T Vander Borght","year":"1997","unstructured":"Vander Borght T, Minoshima S, Giordani B, Foster NL, Frey KA, Berent S et al (1997). Cerebral metabolic differences in Parkinson\u2019s and Alzheimer\u2019s diseases matched for dementia severity. J Nucl Med 38: 797\u2013802.","journal-title":"J Nucl Med"},{"issue":"1 Suppl","key":"BFnpp2012255_CR43","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.jalz.2011.09.172","volume":"8","author":"MW Weiner","year":"2012","unstructured":"Weiner MW, Veitch DP, Aisen PS, Beckett LA, Cairns NJ, Green RC et al (2012). The Alzheimer\u2019s Disease Neuroimaging Initiative: a review of papers published since its inception. Alzheimers Dement 8 (1 Suppl): S1\u2013S68.","journal-title":"Alzheimers Dement"},{"key":"BFnpp2012255_CR44","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0896-6273(02)00794-8","volume":"35","author":"T Wyss-Coray","year":"2002","unstructured":"Wyss-Coray T, Mucke L (2002). Inflammation in neurodegenerative disease\u2014a double-edged sword. Neuron 35: 419\u2013432.","journal-title":"Neuron"},{"key":"BFnpp2012255_CR45","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1111\/j.1468-1331.2007.01977.x","volume":"14","author":"SW Yong","year":"2007","unstructured":"Yong SW, Yoon JK, An YS, Lee PH (2007). A comparison of cerebral glucose metabolism in Parkinson\u2019s disease, Parkinson\u2019s disease dementia and dementia with Lewy bodies. Eur J Neurol 14: 1357\u20131362.","journal-title":"Eur J Neurol"},{"key":"BFnpp2012255_CR46","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1096\/fj.04-2751com","volume":"19","author":"W Zhang","year":"2005","unstructured":"Zhang W, Wang T, Pei Z, Miller DS, Wu X, Block ML et al (2005). Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson\u2019s disease. Faseb J 19: 533\u2013542.","journal-title":"Faseb J"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2012255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2012255","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2012255.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,28]],"date-time":"2023-06-28T10:38:55Z","timestamp":1687948735000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2012255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,6]]},"references-count":46,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["BFnpp2012255"],"URL":"https:\/\/doi.org\/10.1038\/npp.2012.255","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,6]]}}}